On the eve of World AIDS Day on Dec. 1, Richmond’s bioLytical is being recognized for its work.
Richmond’s bioLytical B.C. exporter of the year
Published 11:23 PST, Tue November 26, 2019
Last Updated: 2:13 PDT, Wed May 12, 2021
A local biotech company has been named B.C. exporter of the year.
Richmond-based bioLytical is a world leader in rapid diagnostic tests for infectious diseases.
“We are honoured to be selected from such an exceptional group of companies,” said Livleen Veslemes, bioLytical’s CEO. “This award reflects our team’s dedication and hard work. As a Canadian success story, we are grateful to have the opportunity to serve the international HIV community and are proud that 17 million people have chosen our proprietary platform, INSTI, to learn their HIV status. With tremendous progress in science, the world has a better chance than ever before to end the HIV epidemic, and it all starts with access to testing; this is why export is one of the most important parts of our business.”
BC Export Awards judge Kirk LaPointe said, "The judges viewed bioLytical as not only a company with a valued medical advance but one with an important mission. Its efforts are the best possible example of what British Columbian business can contribute to the wider world.”
bioLytical has grown remarkably to become an established global diagnostics leader. Known for outstanding performance, bioLytical’s suite of INSTI tests use innovative technology to deliver results in one-minute with greater than 99 per cent accuracy.
bioLytical exports its INSTI tests to more than 60 countries, supporting programs on the front lines of HIV prevention and care. Despite being recognized as a chronic manageable condition, HIV remains a global health threat and rates are increasing in some regions. UNAIDS has endorsed testing as the first step toward ending HIV and this month the World Health Organization strongly recommended for countries to adopt rapid tests, like INSTI, over traditional methods.